9 Mar 2020
ISARIC associated paper and first study on COVID19 that analyses a number of patients to assess health characteristics that lead to death in hospitalised adults in Wuhan, China.
See full article here: https://www.sciencedaily.com/releases/2020/03/200309130109.htm
Also By
ISARIC
- Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
- What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? - A harmonised, global longitudinal observational study
- An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a rando
Please Sign in (or Register) to view further.